Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis
暂无分享,去创建一个
Ivan Rusyn | Stephen S. Hecht | Robert J. Kavlock | Robert A. Baan | Kurt Straif | Christopher J. Portier | John R. Bucher | Kathryn Z. Guyton | Jane C. Caldwell | David M. DeMarini | Catherine F. Gibbons | K. Straif | I. Rusyn | K. Guyton | B. Stewart | R. Kavlock | J. Bucher | R. Baan | V. Cogliano | Martyn T. Smith | C. Portier | J. Caldwell | D. DeMarini | P. Lambert | S. Hecht | Vincent J. Cogliano | C. Gibbons | Jason M Fritz | Jason M. Fritz | Paul F. Lambert | Bernard W. Stewart | S. Hecht
[1] E. Walshaw,et al. A systematic approach , 2018, BDJ.
[2] Y. Shukla,et al. Current perspectives of molecular pathways involved in chronic inflammation-mediated breast cancer. , 2016, Biochemical and biophysical research communications.
[3] Ivan Rusyn,et al. Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review. , 2016, Mutation research. Reviews in mutation research.
[4] Shih-Heng Chen,et al. Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration. , 2016, Current opinion in pharmacology.
[5] H. Druckrey,et al. 4 The relation of Cancer Induction and Genetic Damage , 2016 .
[6] Polybrominated Biphenyls. Polychlorinated Biphenyls and Polybrominated Biphenyls. , 2016, IARC monographs on the evaluation of carcinogenic risks to humans.
[7] P. Tsao,et al. Diabetic Cardiovascular Disease Induced by Oxidative Stress , 2015, International journal of molecular sciences.
[8] Kurt Straif,et al. Carcinogenicity of lindane, DDT, and 2,4-dichlorophenoxyacetic acid. , 2015, The Lancet. Oncology.
[9] C. Harris. Cause and Prevention of Human Cancer. , 2015, Carcinogenesis.
[10] W. Rathmell,et al. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis. , 2015, Carcinogenesis.
[11] Anna C. Salzberg,et al. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead , 2015, Carcinogenesis.
[12] Kurt Straif,et al. Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate. , 2015, The Lancet. Oncology.
[13] Thomas M. Keane,et al. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer , 2014, Nature.
[14] D Andrews,et al. Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 , 2014, Cell Death and Differentiation.
[15] T. Douki,et al. DNA damage in internal organs after cutaneous exposure to sulphur mustard. , 2014, Toxicology and applied pharmacology.
[16] Tracey J. Woodruff,et al. The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Human Evidence for PFOA Effects on Fetal Growth , 2014, Environmental health perspectives.
[17] Division on Earth. Review of Epa's Integrated Risk Information System (Iris) Process , 2014 .
[18] Paula I. Johnson,et al. The Navigation Guide—Evidence-Based Medicine Meets Environmental Health: Systematic Review of Nonhuman Evidence for PFOA Effects on Fetal Growth , 2014, Environmental health perspectives.
[19] John R. Bucher,et al. Systematic Review and Evidence Integration for Literature-Based Environmental Health Science Assessments , 2014, Environmental health perspectives.
[20] H. Naegeli,et al. Low-Dose Formaldehyde Delays DNA Damage Recognition and DNA Excision Repair in Human Cells , 2014, PloS one.
[21] S. H. Baek,et al. Emerging roles of orphan nuclear receptors in cancer. , 2014, Annual review of physiology.
[22] S. Ryter,et al. The Impact of Autophagy on Cell Death Modalities , 2014, International journal of cell biology.
[23] Ivan Rusyn,et al. A systematic approach for identifying and presenting mechanistic evidence in human health assessments. , 2013, Regulatory toxicology and pharmacology : RTP.
[24] M. Allday. EBV finds a polycomb-mediated, epigenetic solution to the problem of oncogenic stress responses triggered by infection , 2013, Front. Genet..
[25] Paolo Vineis,et al. Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. , 2013, Carcinogenesis.
[26] Melvin E. Andersen,et al. Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven Framework , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[27] A. Camargo,et al. Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health. , 2013, Antioxidants & redox signaling.
[28] M. Little,et al. Non-targeted effects of ionising radiation--implications for low dose risk. , 2013, Mutation research.
[29] K. Straif,et al. Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls. , 2013, The Lancet. Oncology.
[30] M. Banerjee,et al. Role of genomic instability in arsenic-induced carcinogenicity. A review. , 2013, Environment international.
[31] M. Redinbo,et al. Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective , 2013, Drug metabolism reviews.
[32] A. Palucka,et al. Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet? , 2013, Science.
[33] Robert J Kavlock,et al. In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.
[34] Ivan Rusyn,et al. Environmental toxicants, epigenetics, and cancer. , 2013, Advances in experimental medicine and biology.
[35] David M. Wilson,et al. Pathways for repairing and tolerating the spectrum of oxidative DNA lesions. , 2012, Cancer letters.
[36] Stephen S Hecht,et al. Lung carcinogenesis by tobacco smoke , 2012, International journal of cancer.
[37] M. Filipič. Mechanisms of cadmium induced genomic instability. , 2012, Mutation research.
[38] Gabriele Multhoff,et al. Radiation, Inflammation, and Immune Responses in Cancer , 2012, Front. Oncol..
[39] G. Trinchieri. Cancer and inflammation: an old intuition with rapidly evolving new concepts. , 2012, Annual review of immunology.
[40] P. Bugelski,et al. Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice , 2012, Journal of immunotoxicology.
[41] Luoping Zhang,et al. Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment. , 2012, Carcinogenesis.
[42] Kurt Straif,et al. Preventable exposures associated with human cancers. , 2011, Journal of the National Cancer Institute.
[43] Q. Ma. Influence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology and disease , 2011, Expert opinion on drug metabolism & toxicology.
[44] Shaoyu Zhou,et al. Oxidative stress and oxidative damage in chemical carcinogenesis. , 2011, Toxicology and applied pharmacology.
[45] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[46] L. Coussens,et al. Leukocytes in mammary development and cancer. , 2011, Cold Spring Harbor perspectives in biology.
[47] J. Higgins. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .
[48] B. Pons,et al. Direct inhibition of excision/synthesis DNA repair activities by cadmium: analysis on dedicated biochips. , 2010, Mutation research.
[49] E. Robertson,et al. Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention , 2010, Cancer biology & therapy.
[50] T. Kunkel,et al. Mutator phenotypes due to DNA replication infidelity. , 2010, Seminars in cancer biology.
[51] B. Preston,et al. DNA replication fidelity and cancer. , 2010, Seminars in cancer biology.
[52] M. Karin,et al. Immunity, Inflammation, and Cancer , 2010, Cell.
[53] A. Zuckerman,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.
[54] D. DeMarini,et al. Types and Consequences of DNA Damage , 2009 .
[55] K. Straif,et al. A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.
[56] D. DeMarini,et al. Chemoprevention of Cancer and DNA Damage by Dietary Factors , 2009 .
[57] Jiri Aubrecht,et al. Community address: www.elsevier.com/locate/mutres Review , 2022 .
[58] T. Kiyono,et al. Molecular mechanisms of cervical carcinogenesis by high‐risk human papillomaviruses: novel functions of E6 and E7 oncoproteins , 2009, Reviews in medical virology.
[59] J. Pollard,et al. Macrophages define the invasive microenvironment in breast cancer , 2008, Journal of leukocyte biology.
[60] A. Zhitkovich,et al. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. , 2008, Chemical research in toxicology.
[61] humAn cArcinogens,et al. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 97. 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). , 2008, IARC monographs on the evaluation of carcinogenic risks to humans.
[62] K. Straif,et al. Carcinogenicity of 1,3-butadiene, ethylene oxide, vinyl chloride, vinyl fluoride, and vinyl bromide. , 2007, The Lancet. Oncology.
[63] M. Kazanietz,et al. Protein kinase C and other diacylglycerol effectors in cancer , 2007, Nature Reviews Cancer.
[64] P. Hartge,et al. Environmental and Behavioral Factors and the Risk of Non-Hodgkin Lymphoma , 2007, Cancer Epidemiology Biomarkers & Prevention.
[65] Lawrence D True,et al. Human cancers express a mutator phenotype , 2006, Proceedings of the National Academy of Sciences.
[66] Ivan Rusyn,et al. Effects of ethylene oxide and ethylene inhalation on DNA adducts, apurinic/apyrimidinic sites and expression of base excision DNA repair genes in rat brain, spleen, and liver. , 2005, DNA repair.
[67] F. O’Sullivan,et al. Hypoxia and Glucose Metabolism in Malignant Tumors , 2004, Clinical Cancer Research.
[68] D. Mankoff,et al. Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by ( 18 F)Fluoromisonidazole and ( 18 F)Fluorodeoxyglucose Positron , 2004 .
[69] G. Morgan,et al. Causal models of leukaemia and lymphoma. , 2004, IARC scientific publications.
[70] A. Kong,et al. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. , 2002, Current drug metabolism.
[71] Á. Pascual,et al. Nuclear hormone receptors and gene expression. , 2001, Physiological reviews.
[72] C. Walker. Polychlorinated biphenyls and polybrominated biphenyls , 2001 .
[73] A. Klingelhutz. The roles of telomeres and telomerase in cellular immortalization and the development of cancer. , 1999, Anticancer research.
[74] Martyn T. Smith,et al. The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. , 1996, Environmental health perspectives.
[75] L. Ehrenberg. Covalent binding of genotoxic agents to proteins and nucleic acids. , 1984, IARC scientific publications.
[76] T. Slaga,et al. Multistage chemical carcinogenesis in mouse skin. , 1980, Current problems in dermatology.
[77] J A Miller,et al. Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture. , 1970, Cancer research.